Development of distamycin-related DNA binding anticancer drugs

Author： Marchini Sergio Broggini Massimo Sessa Cristiana D’Incalci Maurizio

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.10, Iss.9, 2001-09, pp. : 1703-1714

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Semi-Automatic Synthesis of Distamycin Analogues and their DNA Binding Properties

Letters in Drug Design & Discovery, Vol. 9, Iss. 1, 2012-01 ,pp. : 12-16

Bentham Science Publishers

Access to resources Recommend Favorite

Methods for Elucidation of DNA-Anticancer Drug Interactions and their Applications in the Development of New Drugs

Current Pharmaceutical Design, Vol. 22, Iss. 44, 2017-01 ,pp. : 6596-6611

Bentham Science Publishers

Access to resources Recommend Favorite

DNA minor groove alkylating agents structurally related to distamycin A

By Baraldi P.G. Spalluto G. Cacciari B. Romagnoli R.

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 6, 2000-06 ,pp. : 891-904

Informa Healthcare

Access to resources Recommend Favorite

Taxol Anticancer Activity and DNA Binding

Mini Reviews in Medicinal Chemistry, Vol. 5, Iss. 3, 2005-03 ,pp. : 307-311

Bentham Science Publishers

Access to resources Recommend Favorite

Advances in the development of hybrid anticancer drugs

By Fortin Sébastien

Expert Opinion on Drug Discovery, Vol. 8, Iss. 8, 2013-11 ,pp. : 1029-1047

Informa Healthcare

Access to resources Recommend Favorite